The trial met its pre-specified primary endpoint, demonstrating that PDP-716 dosed once daily is equivalent to Alphagan P 0.1% dosed 3 times a day
KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
India's strategy against Covid was more effective than any other countries in the world
Sun Pharma Advanced Research Company has reported standalone financial results for the period ended December 31, 2021
At its meeting, the board also approved raising the company’s authorised share capital to Rs. 42.50 crores from Rs. 37.50 crores.
Subscribe To Our Newsletter & Stay Updated
